Health Condition 1: J00- Acute nasopharyngitis [common cold]
Conditions
Interventions
Intervention1: Mulmina Mango Ready To Drink: Dose: 200ml Dosage form: Oral
Drink Frequency : 1 pack per day for 4 weeks
Route of administrate : Orally
Total duration: 28 days
Intervention2: Azithromyc
Sponsors
Jagdale industries pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: i. Volunteer aged between 7-14 years (both inclusive) ii. Proven to be healthy and parents willing to give written consent to participate
Exclusion criteria
Exclusion criteria: i. Children having cerebral palsy physical disability and children requiring IEP with epilepsy will be excluded from the study ii. Patients with preexisting severe systemic disease necessitating long term medication. iii. Evidence of significant uncontrolled comorbid disease which in the investigators opinion would jeopardize patient participation. iv. Any onco neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments. v. Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Less number (% change) of clinical deteriorations (defined as a significant change in clinical status /hospitalization). 2. Safety aspects in the Groups receiving Mulmina Mango along with antibiotic(s) 3. Significant change in the clinical symptoms in Groups receiving antibiotics along with Mulmina Mango. 4. Significant change in the biomarkers in Groups receiving antibiotics along with Mulmina Mango. Timepoint: Day 0, 7 and 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| General health and Adverse eventsTimepoint: Day 0 to Day 28 | — |
Countries
India
Contacts
Public ContactMr Raghavendra K V
Radiant Research Services Pvt. Ltd
Outcome results
None listed